Statement of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash flows from operating activities:
Net income attributable to common shareholders	$ (910,272)	$ 5,226,517
Adjustments to reconcile net income to net cash used in operating activities net of changes in assets and liabilities resulting from the sales and purchases of subsidiaries:
Amortization (accretion) of investments	(403,748)	(975,910)
Realized investment gains, net	(44,723)	(7,135,970)
Unrealized trading gains included in income	297,344	(528,698)
Amortization of deferred policy acquisition costs	14,108	15,512
Amortization of cost of insurance acquired	266,088	286,375
Depreciation	320,071	446,177
Net income attributable to noncontrolling interest	146,081	273,214
Charges for mortality and administration of universal life and annuity products	(1,737,635)	(1,789,191)
Interest credited to account balances	1,450,681	1,422,593
Change in accrued investment income (loss)	350,518	(535,714)
Change in reinsurance receivables	927,606	718,638
Change in policy liabilities and accruals	(1,121,391)	(462,586)
Change in income taxes receivable (payable)	(1,982,692)	2,664,281
Change in other assets and liabilities, net	1,624,775	(1,245,683)
Net cash provided by (used in) operating activities	(803,189)	(1,620,445)
Proceeds from investments sold and matured:
Fixed maturities available for sale	6,173,142	49,673,705
Equity securities available for sale	0	296,399
Trading securities	17,829,177	3,863,825
Mortgage loans	7,785,104	2,430,247
Discounted mortgage loans	1,505,565	3,257,451
Real estate	2,733,460	8,173,899
Policy loans	997,774	1,134,602
Short term investments	29,383	0
Total proceeds from investments sold and matured	37,053,605	68,830,128
Cost of investments acquired:
Fixed maturities available for sale	(8,856,558)	(85,553,891)
Equity securities available for sale	(250,617)	(166,407)
Trading securities	(15,124,263)	(3,443,030)
Mortgage loans	(1,122,724)	(392)
Discounted mortgage loans	(1,280,456)	(5,875,374)
Real estate	(5,918,258)	(3,203,558)
Policy loans	(803,607)	(749,810)
Payments for (Proceeds from) Other Investing Activities	(25,000)	0
Total cost of investments acquired	(33,381,483)	(98,992,462)
Net cash used in investing activities	3,672,122	(30,162,334)
Cash flows from financing activities:
Policyholder contract deposits	1,521,403	1,617,272
Policyholder contract withdrawals	(1,360,777)	(1,638,400)
Proceeds from notes payable/line of credit	0	350,000
Payments of principal on notes payable/line of credit	(9,500)	(359,347)
Purchase of treasury stock	(54,048)	(433,177)
Distributions to minority interests of consolidated subsidiaries	0	(10,000)
Net cash provided by (used in) financing activities	97,078	(473,652)
Net increase (decrease) in cash and cash equivalents	2,966,011	(32,256,431)
Cash and cash equivalents at beginning of period	23,321,246	82,925,675
Cash and cash equivalents at end of period	$ 26,287,257	$ 50,669,244